Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025
Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements. Dr. Roxana Kia, CEO of Nexus, a subsidiary of the Actover Pharmaceutical Group, called attention to the regulatory imbalance that continues to disadvantage licensed domestic supplement manufacturers in favor of imported, and often […]
Labor Day Tribute from Actover
May 1st – International Labor Day International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor those whose dedication, expertise, and commitment drive the engines of progress and prosperity. At Actover, we believe that human capital is not only the […]
Nahaleh Naraqi honors Pharmacy Day with a special message!
Nahale Naraghi honors Pharmacy Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being
I would like to extend my congratulations and best wishes to all professors, industry professionals, and the large family of Iranian pharmacists, especially to my dear colleagues at the Actover Group, on the occasion of the 5th of Shahrivar, the birthday of the great Iranian scholar and physician Muhammad ibn Zakariya al-Razi, which is also celebrated as Pharmacist Day.
Nahale Naraghi honors National Doctors Day in Iran!
On this special occasion of National Doctors Day, which coincides with the birthday of the esteemed Persian scholar Avicenna, Nahaleh Naraghi, extends heartfelt gratitude to all the doctors across Iran. In a message reflecting the deep respect for the medical community, Ms. Naraghi highlights the enduring legacy of Avicenna, whose contributions to medicine continue to inspire […]
Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”
The pharmaceutical company “Atipharmed,” a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone therapy and alleviating post-menopause symptoms and issues. According to the public relations department of the Actover Group, Atipharmed’s new drugs include the vaginal tablet Gynati, containing 10 micrograms of the sex […]
Visual Report on the Introduction of Actonib and Its application in Dermatology
Baricitinib is the first drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe stages of alopecia areata in adults. This medicine, marketed under the name Actonib, is produced by Actoverco pharmaceutical group . Consequently, an event was held with the presence of prominent specialists from various fields […]
Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran
Baricitinib, marketed under the brand name Actonib, is the first FDA-approved medication for the treatment of moderate to severe alopecia areata in adults. This drug, manufactured by Alborz-Zagros Pharmaceutical Company, a subsidiary of the Actoverco pharmaceutical group, is the only high-risk drug production facility in Iran with GMP certification. Actonib is taken once daily and […]
Neurostyle Launch Event
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company (subsidiary company of Actoverco) announced that Neurostyle, produced in tablet form by Nexus specialists, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections. Nexus has distributed new products in the form of tablets, soft gels, and effervescent tablets, and […]
Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
Dr. Roxana Kia, CEO of Nexus Pharmaceutical Company, announced that this supplement, produced in tablet form by Nexus specialists from the Actoverco Pharmaceutical Group, can be used by both ordinary individuals and those with diabetes who have difficulties with medication injections. She stated that the ingredients used in the Neurostyle supplement include B vitamins, and […]
Actoverco launches diabetes drug “Trytis”
According to Actoverco pharmaceutical Group; Trytis is going to be launched and released on the market soon. Trytis is an oral combination diabetes medication used to control blood sugar in people with type 2 diabetes. This drug is a combination of metformin, empagliflozin and linagliptin, which reduces blood sugar with three different mechanisms. Approximately […]